Evaluation of mortality following paclitaxel drug-coated stent angioplasty of femoropopliteal lesions in real world.
Tanja BöhmeElias NooryUlrich BeschornerBörries JacquesKarlheinz BürgelinRoland MacharzinaThomas NührenbergFlorian CheungFranz-Josef NeumannThomas ZellerPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In real world, long-term mortality rate was lower after DES angioplasty than after treatment with uncoated devices. Mortality predictors were co-morbidities, risk factors, and disease severity.